Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Chartrel

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Endocrinology|January 24, 2009
The orexigenic activity of the hypothalamic neuropeptide 26RFa is mediated by the neuropeptide Y and proopiomelanocortin neurons of the arcuate nucleusBenoît Lectez, Lydie Jeandel, Fatima-Zohra El-Yamani, et al.
European Journal of Cancer (Oxford, England : 1990)|October 14, 2014
Secretogranin II is overexpressed in advanced prostate cancer and promotes the neuroendocrine differentiation of prostate cancer cellsMaïté Courel, Fatima-Zohra El Yamani, David Alexandre, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 2003
Identification of 26RFa, a hypothalamic neuropeptide of the RFamide peptide family with orexigenic activityNicolas Chartrel, Cynthia Dujardin, Youssef Anouar, et al.
Discover Mental Health|November 20, 2023
Immunoglobulin G is a natural oxytocin carrier which modulates oxytocin receptor signaling: relevance to aggressive behavior in humansHenning Værøy, Emilie Lahaye, Christophe Dubessy, et al.
Molecules (Basel, Switzerland)|July 24, 2021
Point-Substitution of Phenylalanine Residues of 26RFa Neuropeptide: A Structure-Activity Relationship StudyBenjamin Lefranc, Karima Alim, Cindy Neveu, et al.
Neuropeptides|February 15, 2023
Interactions between the regulatory peptide 26RFa (QRFP) and insulin in the regulation of glucose homeostasis in two complementary models: The high fat 26RFa-deficient mice and the streptozotocin insulin-deficient miceMarie-Anne Le Solliec, Arnaud Arabo, Saloua Takhlidjt, et al.
Journal of Neurochemistry|August 20, 2008
Characterization of urotensin II, distribution of urotensin II, urotensin II-related peptide and UT receptor mRNAs in mouse: evidence of urotensin II at the neuromuscular junctionChristophe Dubessy, Dorthe Cartier, Benoît Lectez, et al.
European Journal of Cancer (Oxford, England : 1990)|August 7, 2012
The neuropeptide 26RFa is expressed in human prostate cancer and stimulates the neuroendocrine differentiation and the migration of androgeno-independent prostate cancer cellsJessy Alonzeau, David Alexandre, Lydie Jeandel, et al.
Frontiers in Neuroscience|July 23, 2016
New Insights in Anorexia NervosaPhilip Gorwood, Corinne Blanchet-Collet, Nicolas Chartrel, et al.
Diabetologia|April 27, 2022
The 26RFa (QRFP)/GPR103 neuropeptidergic system in mice relays insulin signalling into the brain to regulate glucose homeostasisMouna El Mehdi, Saloua Takhlidjt, Mélodie Devère, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Endocrinology|January 24, 2009
The orexigenic activity of the hypothalamic neuropeptide 26RFa is mediated by the neuropeptide Y and proopiomelanocortin neurons of the arcuate nucleusBenoît Lectez, Lydie Jeandel, Fatima-Zohra El-Yamani, et al.
European Journal of Cancer (Oxford, England : 1990)|October 14, 2014
Secretogranin II is overexpressed in advanced prostate cancer and promotes the neuroendocrine differentiation of prostate cancer cellsMaïté Courel, Fatima-Zohra El Yamani, David Alexandre, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 2003
Identification of 26RFa, a hypothalamic neuropeptide of the RFamide peptide family with orexigenic activityNicolas Chartrel, Cynthia Dujardin, Youssef Anouar, et al.
Discover Mental Health|November 20, 2023
Immunoglobulin G is a natural oxytocin carrier which modulates oxytocin receptor signaling: relevance to aggressive behavior in humansHenning Værøy, Emilie Lahaye, Christophe Dubessy, et al.
Molecules (Basel, Switzerland)|July 24, 2021
Point-Substitution of Phenylalanine Residues of 26RFa Neuropeptide: A Structure-Activity Relationship StudyBenjamin Lefranc, Karima Alim, Cindy Neveu, et al.
Neuropeptides|February 15, 2023
Interactions between the regulatory peptide 26RFa (QRFP) and insulin in the regulation of glucose homeostasis in two complementary models: The high fat 26RFa-deficient mice and the streptozotocin insulin-deficient miceMarie-Anne Le Solliec, Arnaud Arabo, Saloua Takhlidjt, et al.
Journal of Neurochemistry|August 20, 2008
Characterization of urotensin II, distribution of urotensin II, urotensin II-related peptide and UT receptor mRNAs in mouse: evidence of urotensin II at the neuromuscular junctionChristophe Dubessy, Dorthe Cartier, Benoît Lectez, et al.
European Journal of Cancer (Oxford, England : 1990)|August 7, 2012
The neuropeptide 26RFa is expressed in human prostate cancer and stimulates the neuroendocrine differentiation and the migration of androgeno-independent prostate cancer cellsJessy Alonzeau, David Alexandre, Lydie Jeandel, et al.
Frontiers in Neuroscience|July 23, 2016
New Insights in Anorexia NervosaPhilip Gorwood, Corinne Blanchet-Collet, Nicolas Chartrel, et al.
Diabetologia|April 27, 2022
The 26RFa (QRFP)/GPR103 neuropeptidergic system in mice relays insulin signalling into the brain to regulate glucose homeostasisMouna El Mehdi, Saloua Takhlidjt, Mélodie Devère, et al.
Pageof 6